FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312065202> ?p ?o ?g. }

• W4312065202 abstract "Vaccines are used as one of the major weapons for the eradication of pandemic. However, the rise of different variants of the SARS-CoV-2 virus is creating doubts regarding the end of the pandemic. Hence, there is an urgent need to develop more drug candidates which can be useful for the treatment of COVID-19. In the present research for the scientific hypothesis, emphasis was given on the direct antiviral therapy available for the treatment of COVID-19. In lieu of this, the available molecular targets which include Severe Acute Respiratory Syndrome Chymotrypsin-like Protease (SARS-3CLpro), Papain-Like Cysteine Protease (PLpro), and RNA-Dependent RNA Polymerase (RdRp) were explored. As per the current scientific reports and literature, among all the available molecular targets, RNA-Dependent RNA Polymerase (RdRp) was found to be a crucial molecular target for the treatment of COVID-19. Most of the inhibitors which are reported against this target consisted of the free amine group and carbonyl group which might be playing an important role in the binding interaction with the RdRp protein. Among all the reported RdRp inhibitors, remdesivir, favipiravir, and molnupiravir were found to be the most promising drugs against COVID-19. Overall, the structural features of this RNA-Dependent RNA Polymerase (RdRp) inhibitors proved the importance of pyrrolo-triazine and pyrimidine scaffolds. Previous computational models of these drug molecules indicated that substitution with the polar functional group, hydrogen bond donor, and electronegative atoms on these scaffolds may increase the activity against the RdRp protein. Hence, in line with the proposed hypothesis, in the present research work for the evaluation of the hypothesis, new molecules were designed from the pyrrolo-triazine and pyrimidine scaffolds. Further, molecular docking and MD simulation studies were performed with these designed molecules. All these designed molecules (DM-1, DM-2, and DM-3) showed the results as per the proposed hypothesis. Among all the designed molecules, DM-1 showed promising results against the RdRp protein of SARS-CoV-2. In the future, these structural features can be used for the development of new RdRp inhibitors with improved activity. Also, in the future lead compound DM-1 can be explored against the RdRp protein for the treatment of COVID-19." @default.
• W4312065202 created "2023-01-04" @default.
• W4312065202 creator A5018328207 @default.
• W4312065202 creator A5077225821 @default.
• W4312065202 creator A5084754745 @default.
• W4312065202 date "2022-12-16" @default.
• W4312065202 modified "2023-10-11" @default.
• W4312065202 title "A hypothesis on designing strategy of effective RdRp inhibitors for the treatment of SARS-CoV-2" @default.
• W4312065202 cites W2013093113 @default.
• W4312065202 cites W2013669585 @default.
• W4312065202 cites W2136414263 @default.
• W4312065202 cites W2470646526 @default.
• W4312065202 cites W2791400386 @default.
• W4312065202 cites W2914796231 @default.
• W4312065202 cites W3008142620 @default.
• W4312065202 cites W3011093535 @default.
• W4312065202 cites W3012379316 @default.
• W4312065202 cites W3013442544 @default.
• W4312065202 cites W3014067025 @default.
• W4312065202 cites W3015155434 @default.
• W4312065202 cites W3015429854 @default.
• W4312065202 cites W3016148207 @default.
• W4312065202 cites W3020188044 @default.
• W4312065202 cites W3020358199 @default.
• W4312065202 cites W3021640348 @default.
• W4312065202 cites W3023494626 @default.
• W4312065202 cites W3024339709 @default.
• W4312065202 cites W3028036282 @default.
• W4312065202 cites W3029741935 @default.
• W4312065202 cites W3034033967 @default.
• W4312065202 cites W3036139831 @default.
• W4312065202 cites W3039523373 @default.
• W4312065202 cites W3042094126 @default.
• W4312065202 cites W3043979223 @default.
• W4312065202 cites W3044128443 @default.
• W4312065202 cites W3044722686 @default.
• W4312065202 cites W3045750139 @default.
• W4312065202 cites W3046218096 @default.
• W4312065202 cites W3046740971 @default.
• W4312065202 cites W3047500036 @default.
• W4312065202 cites W3084920415 @default.
• W4312065202 cites W3085495358 @default.
• W4312065202 cites W3092192687 @default.
• W4312065202 cites W3092736134 @default.
• W4312065202 cites W3093768302 @default.
• W4312065202 cites W3094366892 @default.
• W4312065202 cites W3094827588 @default.
• W4312065202 cites W3100655194 @default.
• W4312065202 cites W3105459316 @default.
• W4312065202 cites W3106029231 @default.
• W4312065202 cites W3108500958 @default.
• W4312065202 cites W3109274291 @default.
• W4312065202 cites W3110790785 @default.
• W4312065202 cites W3111133539 @default.
• W4312065202 cites W3111713404 @default.
• W4312065202 cites W3120330984 @default.
• W4312065202 cites W3123421077 @default.
• W4312065202 cites W3124465081 @default.
• W4312065202 cites W3125094078 @default.
• W4312065202 cites W3125571497 @default.
• W4312065202 cites W3130913583 @default.
• W4312065202 cites W3131304542 @default.
• W4312065202 cites W3132134606 @default.
• W4312065202 cites W3133499696 @default.
• W4312065202 cites W3135375619 @default.
• W4312065202 cites W3139690347 @default.
• W4312065202 cites W3152451364 @default.
• W4312065202 cites W3153506813 @default.
• W4312065202 cites W3163283061 @default.
• W4312065202 cites W3165479483 @default.
• W4312065202 cites W3165737823 @default.
• W4312065202 cites W3168790869 @default.
• W4312065202 cites W3169420394 @default.
• W4312065202 cites W3171090371 @default.
• W4312065202 cites W3178886823 @default.
• W4312065202 cites W3179950639 @default.
• W4312065202 cites W3185071731 @default.
• W4312065202 cites W3195528664 @default.
• W4312065202 cites W3196022336 @default.
• W4312065202 cites W3199569838 @default.
• W4312065202 cites W3199849883 @default.
• W4312065202 cites W3202419497 @default.
• W4312065202 cites W3202890729 @default.
• W4312065202 cites W3204436699 @default.
• W4312065202 cites W3207756882 @default.
• W4312065202 cites W3210805661 @default.
• W4312065202 cites W4212988737 @default.
• W4312065202 cites W4283317183 @default.
• W4312065202 doi "https://doi.org/10.1007/s13205-022-03430-w" @default.
• W4312065202 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36532857" @default.
• W4312065202 hasPublicationYear "2022" @default.
• W4312065202 type Work @default.
• W4312065202 citedByCount "3" @default.
• W4312065202 countsByYear W43120652022023 @default.
• W4312065202 crossrefType "journal-article" @default.
• W4312065202 hasAuthorship W4312065202A5018328207 @default.
• W4312065202 hasAuthorship W4312065202A5077225821 @default.
• W4312065202 hasAuthorship W4312065202A5084754745 @default.
• W4312065202 hasBestOaLocation W43120652021 @default.
• W4312065202 hasConcept C104317684 @default.

• next